Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Feb 14 2022

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-feb-14-2022-10

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 14, 2022, titled "Glenmark inks agreement with Astrazeneca to commercialize its product PulmicortRespules in Columbia".

View Attachment

6ix hasn’t read this filing yet.

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases